Dolomite Bio, headquartered in Royston, Hertfordshire, UK, is a biotechnology company that creates products for high throughput single cell research for biologists.[1] Dolomite Bio is based out of five global offices, with headquarters in the UK and regional offices in the US, Japan, Vietnam and Brazil.[2]

Dolomite Bio
TypePrivate
Industry
  • Scientific Instrumentation
Founded2016 (2016)
Headquarters
Area served
Worldwide
Key people
Mark Gilligan (CEO)
ProductsSingle cell sequencing
Number of employees
~40 (2016)
Websitedolomite-microfluidics.com

Dolomite Bio is part of the Blacktrace Holdings ltd.[3][when?]

History

edit

Dolomite Bio was founded in March 2016 from its sister company Dolomite Microfluidics (part of the Blacktrace group of companies).[4] Dolomite Bio now serves all of Dolomite Microfluidics' biology customers and develops new products specifically for biologists.[5]

Products

edit

Dolomite Bio creates products for high throughput single cell research which can encapsulate single cells in microfluidic droplets.

Dolomite Bio's Nadia Instrument[6] is a fully automated, microfluidic droplet-based platform for single cell research that encapsulates up to 8 samples, in parallel, in under 20 mins. Over 50,000 single cells can be captured per cartridge in a run. The Instrument guides users through all relevant steps of the experiment via a touchscreen interface.

Dolomite Bio also offers an add-on to the Nadia Instrument called Nadia Innovate[7], which turns it into an open system for the development of new single cell protocols and applications. Newly developed protocols can be transferred to the Nadia Instrument for high throughput parallel operation. Users are able to control parameters such as droplet size, droplet frequency, temperature, agitation and timing.

The Nadia platform can be used for single cell RNA-Seq[8] (scRNA-Seq), single nuclei RNA-Seq[9] (sNuc-Seq), plant protoplast RNA-Seq[10] (ppRNA-Seq) and the encapsulation of cells in Agarose beads.[11]

Technology

edit

Dolomite Bio systems employ the principle of microfluidic flow technology focussing to rapidly encapsulate single cells in millions of aqueous droplets in oil. The droplets are identically sized and, depending on the application, can be 10 – 100 μm in diameter.[12]

Advantages of encapsulating cells in microfluidic droplets

edit
  • Enables analysis of millions of individual cells and their biological products (over 105 single-cell libraries/hour).
  • Improve efficiency and robustness of single-cell reactions—droplets are small (often 10s to 100s of picolitres), so e.g., effective mRNA concentration is high.
  • Controls micro-reactor volumes and prevents cross-contamination, thus improving reliability and reproducibility of results.
  • Droplets can be used as micro-compartments or micro-reactors.
  • Can capture quantitative data from rare cells.

References

edit
  1. "Blacktrace launches biology-focused Dolomite Bio, aiming to develop products for high throughput single cell research". Technology Network. Retrieved 11 November 2016.
  2. "Locations". Dolomite Bio. Archived from the original on 2020-01-01. Retrieved 2020-09-21.
  3. "Blacktrace Focuses On Biology With The Launch Of Dolomite Bio". Biospace. Retrieved 11 November 2016.
  4. "History". Dolomite Bio. Retrieved 11 November 2016.
  5. "Dolomite Bio". Blacktrace. Retrieved 11 November 2016.
  6. "Nadia Instrument". Dolomite Bio. Archived from the original on 2020-01-01. Retrieved 2020-09-21.
  7. "Nadia Innovate". Dolomite Bio. Archived from the original on 2020-01-01. Retrieved 2020-09-21.
  8. "Single Cell RNA-Seq (scRNA-Seq)". Dolomite Bio. Archived from the original on 2016-12-29. Retrieved 2020-09-21.
  9. "Single Nuclei RNA-Seq (sNuc-Seq)". Dolomite Bio. Archived from the original on 2020-01-01. Retrieved 2020-09-21.
  10. "ppRNA-Seq".
  11. "Agarose Encapsulation". Dolomite Bio. Archived from the original on 2020-01-01. Retrieved 2020-09-21.
  12. "Microfluidic technology". Dolomite Bio. Retrieved 11 November 2016.
edit